Hypertension, Vol 20, 304-313, Copyright © 1992 by American Heart Association
CS Bockman, WB Jeffries, WA Pettinger and PW Abel
Ring segments of superior mesenteric arteries studied in vitro were used to
determine the role of the vascular endothelium in regulating vascular
contractile and relaxant sensitivity in deoxycorticosterone acetate
(DOCA)-salt hypertension. Wistar rats were given DOCA (20 mg/kg s.c. twice
per week) and 1% NaCl drinking water for 5 weeks. In ring segments
containing endothelium, there was a decrease in contractile sensitivity to
arginine vasopressin, no change in contractile sensitivity to
norepinephrine and KCl, and no change in relaxant sensitivity to
acetylcholine or isoproterenol in arteries from hypertensive rats compared
with normotensive controls. Removal of the vascular endothelium by rubbing
had no effect on the contractile response to arginine vasopressin and KCl
or the relaxant response to isoproterenol in control arteries. In arteries
without endothelium, DOCA-salt hypertension caused a threefold increase in
contractile sensitivity for arginine vasopressin, norepinephrine, and KCl;
a 50% reduction in maximal relaxation to isoproterenol; and a threefold
decrease in relaxant sensitivity to sodium nitroprusside. Indomethacin (10
microM) had no effect on contraction or relaxation. However, N- monomethyl
L-arginine unmasked altered contractile sensitivity to norepinephrine in
arteries from DOCA-salt hypertensive rats. These data show that the
endothelium compensates for increased contractile and reduced relaxant
responses of vascular muscle in DOCA-salt hypertension by increasing the
release of endothelium-derived relaxing factor. These data suggest that
altered vascular responsiveness is masked by the endothelium, thus
preventing these alterations from contributing to increased peripheral
resistance during the development of DOCA-salt hypertension.
ARTICLES
Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension
Department of Pharmacology, Creighton University School of Medicine, Omaha, Neb. 68178.
This article has been cited by other articles:
![]() |
F. Vargas, J. M. Moreno, R. Wangensteen, I. Rodriguez-Gomez, and J. Garcia-Estan The endocrine system in chronic nitric oxide deficiency Eur. J. Endocrinol., January 1, 2007; 156(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kobayashi, T. Matsumoto, K. Ooishi, and K. Kamata Differential expression of {alpha}2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H135 - H148. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.F. Hadoke, C. Christy, Y. V. Kotelevtsev, B. C. Williams, C. J. Kenyon, J. R. Seckl, J. J. Mullins, and B. R. Walker Endothelial Cell Dysfunction in Mice After Transgenic Knockout of Type 2, but Not Type 1, 11{beta}-Hydroxysteroid Dehydrogenase Circulation, December 4, 2001; 104(23): 2832 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Alvarez, A. Osuna, R. Wangensteen, and F. Vargas Interaction Between Nitric Oxide and Mineralocorticoids in the Long-Term Control of Blood Pressure Hypertension, March 1, 2000; 35(3): 752 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. White, C. O. Rivera, and C. B. Davison Differential Contribution of Endothelial Function to Vascular Reactivity in Conduit and Resistance Arteries From Deoxycorticosterone-Salt Hypertensive Rats Hypertension, June 1, 1996; 27(6): 1245 - 1253. [Abstract] [Full Text] |
||||
![]() |
H. Makynen, M. Kahonen, X. Wu, P. Arvola, and I. Porsti Endothelial Function in Deoxycorticosterone-NaCl Hypertension : Effect of Calcium Supplementation Circulation, March 1, 1996; 93(5): 1000 - 1008. [Abstract] [Full Text] |
||||
![]() |
A. Bonnardeaux, S. Nadaud, A. Charru, X. Jeunemaitre, P. Corvol, and F. Soubrier Lack of Evidence for Linkage of the Endothelial Cell Nitric Oxide Synthase Gene to Essential Hypertension Circulation, January 1, 1995; 91(1): 96 - 102. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |